N-[[1-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)piperidin-4-yl]methyl]methanesulfonamide
C22H24BrN7O2S — CID 58173404
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[[1-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)piperidin-4-yl]methyl]methanesulfonamide
N-[[1-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)piperidin-4-yl]methyl]methanesulfonamide (PubChem CID 58173404) has the molecular formula C22H24BrN7O2S and a molecular weight of 530.45 g/mol. Its IUPAC name is N-[[1-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)piperidin-4-yl]methyl]methanesulfonamide.
Molecular Properties
| Compound Name | N-[[1-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)piperidin-4-yl]methyl]methanesulfonamide |
|---|---|
| PubChem CID | 58173404 |
| Molecular Formula | C22H24BrN7O2S |
| Molecular Weight | 530.45 g/mol |
| Exact Mass | 529.09 |
| IUPAC Name | N-[[1-(7-amino-6-bromo-3-quinolin-3-ylpyrazolo[1,5-a]pyrimidin-5-yl)piperidin-4-yl]methyl]methanesulfonamide |
| SMILES | CS(=O)(=O)NCC1CCN(c2nc3c(-c4cnc5ccccc5c4)cnn3c(N)c2Br)CC1 |
| InChI | InChI=1S/C22H24BrN7O2S/c1-33(31,32)27-11-14-6-8-29(9-7-14)22-19(23)20(24)30-21(28-22)17(13-26-30)16-10-15-4-2-3-5-18(15)25-12-16/h2-5,10,12-14,27H,6-9,11,24H2,1H3 |
| InChIKey | NIWYKBVQARXJHJ-UHFFFAOYSA-N |
| XLogP | 3.05 |
| TPSA | 118.51 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 530.45 |
| LogP ≤ 5 | 3.05 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 58173404 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.